NICE

U.K. Regulatory Advisor Rejects Roche Cancer Drug
Motley Fool
Wed, 02/26/20 - 11:23 pm
Roche
UK
NICE
Polivy
cancer
NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
Fierce Pharma
Sun, 01/26/20 - 01:40 pm
Novo Nordisk
Saxenda
UK
NICE
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
Fri, 01/17/20 - 12:07 pm
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Fierce Pharma
Sat, 01/4/20 - 07:31 pm
Roche
Tecentriq
NICE
UK
Small-Cell Lung Cancer
The 4 biggest pharma market access stories of 2019
Pharmaforum
Thu, 12/19/19 - 12:16 am
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
Fierce Pharma
Sat, 10/12/19 - 12:32 pm
Clovis Oncology
Rubraca
NICE
UK
PARP inhibitors
Blow to Novartis as NICE rejects migraine drug Aimovig again
Pharmaforum
Thu, 09/26/19 - 10:54 am
Novartis
Aimovig
migraines
NICE
UK cost watchdog recommends Novartis' blindness therapy Luxturna
Yahoo/Reuters
Wed, 09/4/19 - 10:18 am
Novartis
gene therapy
Luxturna
UK
NICE
Spark Therapeutics
GW confident epilepsy drug will get NHS funding despite NICE rejection
Pharmaforum
Fri, 08/23/19 - 12:08 pm
GW Pharma
UK
NHS
NICE
Epidyolex
epilepsy
MSD’s Keytruda plus chemo backed by NICE for lung cancer
Pharmaforum
Fri, 08/9/19 - 10:30 am
Merck
Keytruda
NICE
non-small cell lung cancer
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
Fri, 07/12/19 - 12:14 pm
NICE
UK
NHS
AbbVie
Skyrizi
AstraZeneca
Farxiga
Alnylam's Onpattro back in the game against Ionis, thanks to NICE U-turn
Fierce Pharma
Tue, 07/9/19 - 06:32 pm
Ionis
Tegsedi
RNAi
Alnylam
Onpattro
NICE
After years of delays, NICE backs Celgene’s Revlimid in first-line MM
Pharmaforum
Fri, 05/17/19 - 07:18 pm
Celgene
Revlimid
Multiple Myeloma
NICE
NHS
England
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Tue, 04/9/19 - 08:20 am
Scotland
NICE
migraines
Aimovig
Amgen
Novartis
AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs
Fierce Pharma
Thu, 03/28/19 - 11:50 am
AstraZeneca
Imfinzi
lung cancer
NICE
UK
NICE provides first scientific advice on patient preference
BioCentury
Sat, 02/16/19 - 04:32 pm
NICE
COPD
Novartis
clinical trials`
NICE backs Takeda’s Alunbrig in second-line lung cancer
Pharmaforum
Sat, 02/16/19 - 12:02 am
NICE
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Fri, 01/18/19 - 12:09 am
Eli Lilly
NICE
Verzenio
breast cancer
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
Fri, 01/11/19 - 08:18 pm
NICE
UK
Amgen
Novartis
migraines
Aimovig
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
Fri, 10/26/18 - 09:54 am
NICE
AbbVie
Venclyxto
Roche
Rituxan/MabThera
CLL

Pages